Mario Romano

5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor.

Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins.

Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.

Lipoxin analogs and lipoxin formation in vivo.

Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins.

Lipoxin receptors.

Lipoxin and aspirin-triggered lipoxins.

MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.

Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.

Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins.

Epigenetic regulation of the formyl peptide receptor 2 gene.

Immobilization and delivery of biologically active Lipoxin A using electrospinning technology.

Lipoxin A stimulates endothelial miR-126-5p expression and its transfer microvesicles.

Establishment and long-term culture of human cystic fibrosis endothelial cells.

Mechanisms of endothelial cell dysfunction in cystic fibrosis.

microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A receptor-dependent mechanisms of inflammation resolution and antimicrobial defense.

Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review.

Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis.

The Resolution Approach to Cystic Fibrosis Inflammation.

Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis.

Modeling pulmonary cystic fibrosis in a human lung airway-on-a-chip.

CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells.

3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics.